loader2
Partner With Us NRI

Parnax Lab Ltd share Price Today

Company details

114.34
114.34
55.00
167.90
6M Return 31.18%
1Y Return 80.35%
Mkt Cap.(Cr) 131.33
Volume 5,607
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 5,607

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Parnax Lab Ltd shares SWOT Analysis

Strengths (6)

  • Company with high TTM EPS Growth
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Weakness (2)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 114.3
R2 114.3
R3 114.3
Pivot

114.34

S1 114.3
S2 114.3
S3 114.3
EMA SMA
106.9
110.4
108.0
100.4
104.4
118.5
108.5
98.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
NAVRATANMAL BADOLA (HUF) Bulk Sell 2018-05-18 55.27 53695 BSE
DHEERAJ KUMAR LOHIA Bulk Purchase 2018-04-24 58.81 53737 BSE
BHAVIN Y MEHTA Bulk Purchase 2017-06-05 52.25 47315 BSE
Name Category Shares
Binoy Baiju Shah PROMOTER 11.92%
Ila B Shah PROMOTER 11.86%
Baiju Mahasukhlal Shah PROMOTER 11.57%
Prakash Mahasukhlal Shah PROMOTER 10.46%
Mihir Prakash Shah PROMOTER 9.94%
Pragna Prakash Shah PROMOTER 9.28%
Ami Mihir Shah PROMOTER 7.26%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Parnax Lab Ltd Stocks COMPARISON

Financials( in Cr) Parnax Lab Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 114.34 1,520.95 1,574.80 4,564.50 1,078.95
% Change -2 0.33 0.64 -0.53 -2.76
Mcap Cr 131.33 364,926.86 127,144.16 121,173.33 108,567.62
Revenue TTM Cr 167.61 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 8.63 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 13.66 36.46 29.85 75.71 28.16
1 Year Return 80.35 51.82 55.73 27.33 94.70
ROCE 14.66 16.79 14.76 19.30 16.25
ROE 15.64 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 62.16 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,550.52 645.34
LAST 3M 103,712.87 -29,605.88
LAST 6M 176,931.00 -14,371.69
LAST 12M 290,309.13 100,312.35

Parnax Lab Ltd Information

Stock PE (TTM)
13.66
Promoter Holding
72.3%
Book Value
62.3176
ROCE
14.66%
ROE
15.64%
Description
  • Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar`s prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh. Naxpar`s key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.

Registered Address

Gala 114 Bldg No 8, Jogani Ind Complex Chunabhatti, Mumbai, Maharashtra, 400022

Tel : 91-022-6825 2525
Email : compliance:naxparlab.com
Website : http://www.naxparlab.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 50
BSE Code : 506128
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE383L01019

FAQ’s on Parnax Lab Ltd Shares

You can buy Parnax Lab Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Parnax Lab Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 18, 2024 04:01 PM the closing price of Parnax Lab Ltd was Rs.114.34.

The latest PE ratio of Parnax Lab Ltd as of Jun 18, 2024 04:01 PM is 13.66

The latest PB ratio of Parnax Lab Ltd as of Jun 18, 2024 04:01 PM is 0.55

The 52-week high of Parnax Lab Ltd share price is Rs. 167.90 while the 52-week low is Rs. 55.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 18, 2024 04:01 PM, the market cap of Parnax Lab Ltd stood at Rs. 131.33.

Download App

Download Our App

Play Store App Store
market app